Renin inhibition: a novel therapy for cardiovascular disease

American Heart Journal
C Lin, W H Frishman

Abstract

The renin-angiotensin system (RAS) is a major contributor in the regulation of blood pressure, and pharmacologic manipulation of this system has resulted in a beneficial class of therapeutic agents, which include angiotensin-converting enzyme (ACE) inhibitors. However, ACE inhibitors are not specific for RAS, and in addition, they can affect bradykinin and prostaglandin, which can also cause changes in vascular tone. Under development are renin inhibitors that are specific for angiotensinogen and act at the initial, rate-determining step of the RAS cascade. The various pharmacologic approaches to renin inhibition include specific renin antibodies, synthetic derivatives of the prosegment of renin precursor, pepstatin analogs, and angiotensinogen analogs. The last approach is the most promising for patient therapy. Multiple studies have shown the effectiveness of the renin inhibitors in both primates and human beings. Further research is now directed toward the development of an agent with good oral bioavailability for patient treatment and as a biologic probe for helping to understand the role of the RAS in control of blood pressure and blood volume.

References

Nov 1, 1977·Archives of Internal Medicine·H GavrasJ H Laragh
Dec 1, 1992·Hypertension·H D KleinertJ Cohen
Mar 1, 1990·Journal of Cardiovascular Pharmacology·M BursztynH Gavras
Jan 1, 1990·Journal of Cardiovascular Pharmacology·H N GlassmanR R Luther
Sep 1, 1991·Journal of Cardiovascular Pharmacology·E CamenzindH R Brunner
Dec 1, 1991·American Journal of Hypertension·M ShibasakiT Fujikura
Jul 1, 1990·Hypertension·P CorvolJ Ménard
Jul 28, 1990·BMJ : British Medical Journal·A H van den MeirackerM A Schalekamp
Jan 1, 1990·Journal of Ocular Pharmacology·W J GiardinaH H Stein
Dec 1, 1990·The American Journal of Cardiology·P W AndersonW A Hsueh
Jan 1, 1987·Journal of Cardiovascular Pharmacology·T KokubuY Iijima
May 1, 1989·American Journal of Hypertension·E ClauserP Corvol
Jun 1, 1989·Hypertension·P F MentoB M Wilkes
Apr 1, 1989·Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension·C LacourD Nisato
Apr 1, 1989·Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension·E Haber
May 1, 1989·British Journal of Clinical Pharmacology·M de GasparoJ Menard
Dec 1, 1989·Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension·M BursztynH Gavras
Sep 1, 1988·Journal of Medicinal Chemistry·K Y HuiE Haber
Apr 1, 1988·Journal of Medicinal Chemistry·K IizukaY Kiso
Jun 1, 1988·Hypertension·K HiwadaY Iijima
Jan 1, 1987·Clinical and Experimental Hypertension. Part A, Theory and Practice·J M WoodK G Hofbauer
Oct 1, 1987·Journal of Medicinal Chemistry·M G BockG P Vlasuk

❮ Previous
Next ❯

Citations

Mar 20, 2003·Current Diabetes Reports·D A Price, N K Hollenberg
Jun 18, 1998·American Heart Journal·C M O'ConnorK Swedberg
Feb 24, 2001·Journal of Receptor and Signal Transduction Research·M J Robertson
Jun 2, 2007·Journal of Human Hypertension·G T McInnes
Mar 2, 2006·Journal of Hypertension·Michel AziziNorman K Hollenberg
Mar 2, 2006·Pharmacology·Punniyakoti T VeeraveeduYoshifusa Aizawa
Jul 17, 1999·Heart & Lung : the Journal of Critical Care·C M O'ConnorK Swedberg
Aug 25, 2010·Journal of Medicinal Chemistry·Randy L WebbJürgen Maibaum

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Related Papers

Clinical and Experimental Hypertension. Part A, Theory and Practice
E Haber
Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire
S C Tyagi
© 2021 Meta ULC. All rights reserved